Hiring Grantmakers to Unblock Capital Bottleneck – Apply by May 24
We're hiring 10+ grantmakers and senior generalists across our GCR teams. Most of our capital is bottlenecked on a tiny number of people working to identify, vet, and generate strong funding opportunities. Apply here by May 24: https://t.co/73ms02tjNS https://t.co/95v5iYARld
Paying Kidney Donors Could Save Lives and Cut Costs
Nobel laureate Al Roth has a great piece in @washingtonpost today on why we should compensate kidney donors. Kidney failure disproportionately hits Black and low-income Americans, costs Medicare $55B+/yr, and most people who need a transplant will die without one....
Our World in Data Seeks Writer to Simplify Global Challenges
The team behind my favorite graph - @OurWorldInData - is hiring a writer. If you can explain complicated things in ways that change how people think AND you want that skill pointed at the world's largest problems, consider applying: https://t.co/okEO4pBIB4 https://t.co/qC0ZS6SIGe
FDA's 27-Year Freeze Stalled Critical Strep A Vaccine
The FDA accidentally froze Strep A vaccine development for 27 years. @AsimovPress explains what happened and where things stand now, ft. @jacobtrefethen and @coeff_giving's research.
Must‑Read: Atomic Bomb, Band Played On, Caro Books
Making of the atomic bomb was great and I agree belongs on my list along with And the Band Played On! Also all the Caro books
Seeking Page‑Turning, Readable Nonfiction After Fiction Favorites
I usually end up mostly reading fiction because it's easier and more fun than most nonfiction. But I read "And the Band Played On" recently and loved it. Incredibly info-dense, but extremely well-written and page-turning. Any recs for other great...
Updated Chart Highlights Need for New Heading
Claude Code updated the @EpochAIResearch chart for me; I think the heading needs to change. https://t.co/ilbsXFvPSs
Repurposing Approved Drugs: Small Trials Explore New Uses
Great reporting from @Philanthropy on our grantee @CuresWReach, which runs small trials testing whether existing, approved drugs might work for entirely different diseases.